 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Illumina Sees Diagnostics as Largest Growth Opportunity; Dx Strategy to Focus on Cancer
June 20, 2012
Illumina Sees Diagnostics as Largest Growth Opportunity; Dx Strategy to Focus on Cancer
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent
January 8, 2013 / GenomeWeb Daily News - Illumina in Discussions with 100 Potential Clinical Customers for MiSeq, Plans Cancer Diagnostics
April 25, 2012 / Clinical Sequencing News - Macrogen Expands Sequencing Fleet in Preparation for Clinical Sequencing Service Launch
March 28, 2012 / Clinical Sequencing News - Illumina Sees Growing Commercial Customer Base; Doubled Clinical HiSeq Placements in 2011
February 8, 2012 / Clinical Sequencing News - Sequencing Survey Finds Customers Happiest with HiSeq 2500
April 16, 2013 / In Sequence